21030602

Source:http://linkedlifedata.com/resource/pubmed/id/21030602

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282402, umls-concept:C0476089, umls-concept:C0596244, umls-concept:C0920317, umls-concept:C1305855
pubmed:issue	12
pubmed:dateCreated	2010-12-15
pubmed:abstractText	Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9200608
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1538-7755
pubmed:author	pubmed-author:CrosbieEmma JEJ, pubmed-author:EggerMatthiasM, pubmed-author:KitchenerHenry CHC, pubmed-author:RenehanAndrew GAG, pubmed-author:ZwahlenMarcelM
pubmed:copyrightInfo	©2010 AACR.
pubmed:issnType	Electronic
pubmed:volume	19
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3119-30
pubmed:meshHeading	pubmed-meshheading:21030602-Body Mass Index, pubmed-meshheading:21030602-Cohort Studies, pubmed-meshheading:21030602-Endometrial Neoplasms, pubmed-meshheading:21030602-Female, pubmed-meshheading:21030602-Hormone Replacement Therapy, pubmed-meshheading:21030602-Humans, pubmed-meshheading:21030602-Risk Factors
pubmed:year	2010
pubmed:articleTitle	Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.
pubmed:affiliation	Gynaecology Oncology Research Group, School of Cancer and Enabling Sciences, University of Manchester, Manchester, UK.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Meta-Analysis